News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Early Thromboses Cloud Outlook for Novel Stent, Erasmus University Medical Center Study


6/17/2010 7:21:16 AM

MedPage Today -- In an all-comers trial, with two-thirds of patients presenting with complex lesions or comorbidities, the investigational zotarolimus-eluting stent (Resolute) demonstrated noninferiority to the everolimus-eluting Xience, researchers reported.

Read at MedPageToday

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES